Externality and policy intervention in interregional travel with infectious diseases
Health Economics · 2025
DOI: 10.1002/hec.4900 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Economics, 2025. Verfasst von Naoshi Doi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Otaru University of Commerce, Otaru, Hokkaido, Japan. Hauptthemen laut MEDLINE: Travel, Health Policy, Communicable Diseases. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
This paper theoretically investigates externalities and policy interventions in travel during a pandemic. We develop a tractable static model of two regions from a short‐run perspective. The model shows that the externalities can be both negative and positive, depending on regional asymmetry. Thus, even when infectious diseases are widespread, travel restrictions do not necessarily reduce infections and do not necessarily improve social welfare. A formula for the optimal policy intervention is derived and shown to be the weighted average of four types of externalities defined by the direction of travel and the epidemiological status of a traveler.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Otaru University of Commerce, Otaru, Hokkaido, Japan.
- Hiroshima University, Higashi-hiroshima, Hiroshima, Japan.
ORCID-Profile: Naoshi Doi
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Doi, N., & Yamazaki, S. (2025). Externality and policy intervention in interregional travel with infectious diseases. Health Economics. https://doi.org/10.1002/hec.4900
Vancouver
Doi N, Yamazaki S. Externality and policy intervention in interregional travel with infectious diseases. Health Economics. 2025. doi:10.1002/hec.4900
BibTeX
@article{Doi2025,
author = {Doi, Naoshi and Yamazaki, Shingo},
title = {Externality and policy intervention in interregional travel with infectious diseases},
journal = {Health Economics},
year = {2025},
doi = {10.1002/hec.4900}
}
EUVIMED